UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients

Haematologica (Roma), 2020-07, Vol.105 (7), p.1868-1878

2020

Volltextzugriff (PDF)

Calreticulin arms NK cells against leukemia

Oncoimmunology, 2020-01, Vol.9 (1), p.1671763-1671763

2020

Volltextzugriff (PDF)

TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients

Oncoimmunology, 2021-01, Vol.10 (1), p.1889822-1889822

2021

Volltextzugriff (PDF)

TIGIT is a key inhibitory checkpoint receptor in lymphoma

Journal for immunotherapy of cancer, 2023-06, Vol.11 (6), p.e006582

2023

Volltextzugriff (PDF)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma

Journal for immunotherapy of cancer, 2020-12, Vol.8 (2), p.e001235

2020

Volltextzugriff (PDF)

Therapeutic activity of high-dose intratumoral IFN-β requires direct effect on the tumor vasculature

The Journal of immunology (1950), 2014-10, Vol.193 (8), p.4254-4260

2014

Volltextzugriff (PDF)

Phase 1 study of lenalidomide plus dose‐adjusted EPOCH‐R in patients with aggressive B‐cell lymphomas with deregulated MYC and BCL2

Cancer, 2019-06, Vol.125 (11), p.1830-1836

2019

Volltextzugriff (PDF)

Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL

Clinical lymphoma, myeloma and leukemia, 2024-02, Vol.24 (2), p.83-93

2024

Volltextzugriff (PDF)

Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses

Leukemia & lymphoma, 2021-05, Vol.62 (6), p.1497-1501

2021

Volltextzugriff (PDF)

FLT3 inhibitor maintenance after allogeneic stem cell transplantation in FLT3-mutated acute myeloid leukemia (AML) patients

Annals of translational medicine, 2024-06, Vol.12 (3), p.49

2024

Volltextzugriff (PDF)

Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patients

Journal of geriatric oncology, 2021-05, Vol.12 (4), p.585-591

2021

Volltextzugriff (PDF)

Antigen multimers: Specific, sensitive, precise, and multifunctional high-avidity CAR-staining reagents

Matter, 2021-12, Vol.4 (12), p.3917-3940

2021

Volltextzugriff (PDF)

Navigating Dilemmas in Treatment Choice: Our Approach to Supplemental Apheresis Prior to Enrollment in Early- Phase Cellular Therapy Clinical Trials

Transplantation and cellular therapy, 2021-02, Vol.27 (2), p.105-107

2021

Volltextzugriff (PDF)

T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse

Leukemia & lymphoma, 2011-02, Vol.52 (2), p.214-222

2011

Volltextzugriff (PDF)

Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review

Expert opinion on pharmacotherapy, 2005-12, Vol.6 (15), p.2711-2718

2005

Volltextzugriff (PDF)

Abstract 1821: Integrative genomic analysis of diffuse large B cell lymphoma (DLBCL) identifies recurrent oncogenic alterations associated with distinct immune-related clusters

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1821-1821

2021

Volltextzugriff (PDF)

Abstract 6226: Identifying nested spatial units as a conserved organizing principle of the spatial tumor microenvironment

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.6226-6226

2024

Volltextzugriff (PDF)

Eltrombopag Is a Safe and Effective Agent to Treat Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S142-S143

2023

Volltextzugriff (PDF)

178 - Eltrombopag Is a Safe and Effective Agent to Treat Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S142-S143

2023

Volltextzugriff (PDF)

154 - FLT3 Inhibitor Maintenance after Allogeneic Stem Cell Transplantation in FLT3-Mutated Acute Myeloid Leukemia (AML) Patients

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S124-S125

2023

Volltextzugriff (PDF)

FLT3 Inhibitor Maintenance after Allogeneic Stem Cell Transplantation in FLT3-Mutated Acute Myeloid Leukemia (AML) Patients

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S124-S125

2023

Volltextzugriff (PDF)

Outcomes of Older Adults Optimized By Geriatric Assessment-Guided Multidisciplinary Clinic Prior to CAR-T Therapy

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S49-S50

2023

Volltextzugriff (PDF)

58 - Outcomes of Older Adults Optimized By Geriatric Assessment-Guided Multidisciplinary Clinic Prior to CAR-T Therapy

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S49-S50

2023

Volltextzugriff (PDF)

Abstract 778: Cellular and molecular requirements for rejection of B16 melanoma in the setting of regulatory T cell depletion and homeostatic proliferation

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.778-778

2011

Volltextzugriff (PDF)

Impact of Pre-Treatment Whole-Body Metabolic Tumor Volume on Toxicities and Outcomes in Patients Treated with Anti-CD19 CAR T-Cell Therapy for Aggressive Large B-Cell NHL

Transplantation and cellular therapy, 2021-03, Vol.27 (3), p.S193-S194

2021

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(63)

Sprache

Englisch
(63)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(31)
Humans
(17)
Oncology
(12)
Hematology
(10)
Lymphoma
(8)
Immunology
(7)
Female
(6)
Male
(6)
Animals
(5)
Immunotherapy
(5)
Monoclonal Antibodies
(5)
Ophthalmology
(5)
Adult
(4)
B-Cell Lymphoma
(4)
Clinical Trials
(4)
Lymphoma, Large B-Cell, Diffuse - Drug Therapy
(4)
Aged
(3)
Biological And Medical Sciences
(3)
Blood Cancer
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients

Calreticulin arms NK cells against leukemia

TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients

TIGIT is a key inhibitory checkpoint receptor in lymphoma

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma

Therapeutic activity of high-dose intratumoral IFN-β requires direct effect on the tumor vasculature

Phase 1 study of lenalidomide plus dose‐adjusted EPOCH‐R in patients with aggressive B‐cell lymphomas with deregulated MYC and BCL2

Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL

Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses

FLT3 inhibitor maintenance after allogeneic stem cell transplantation in FLT3-mutated acute myeloid leukemia (AML) patients

Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patients

Antigen multimers: Specific, sensitive, precise, and multifunctional high-avidity CAR-staining reagents

Navigating Dilemmas in Treatment Choice: Our Approach to Supplemental Apheresis Prior to Enrollment in Early- Phase Cellular Therapy Clinical Trials

T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse

Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review

Abstract 1821: Integrative genomic analysis of diffuse large B cell lymphoma (DLBCL) identifies recurrent oncogenic alterations associated with distinct immune-related clusters

Abstract 6226: Identifying nested spatial units as a conserved organizing principle of the spatial tumor microenvironment

Eltrombopag Is a Safe and Effective Agent to Treat Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)

178 - Eltrombopag Is a Safe and Effective Agent to Treat Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)

154 - FLT3 Inhibitor Maintenance after Allogeneic Stem Cell Transplantation in FLT3-Mutated Acute Myeloid Leukemia (AML) Patients

FLT3 Inhibitor Maintenance after Allogeneic Stem Cell Transplantation in FLT3-Mutated Acute Myeloid Leukemia (AML) Patients

Outcomes of Older Adults Optimized By Geriatric Assessment-Guided Multidisciplinary Clinic Prior to CAR-T Therapy

58 - Outcomes of Older Adults Optimized By Geriatric Assessment-Guided Multidisciplinary Clinic Prior to CAR-T Therapy

Abstract 778: Cellular and molecular requirements for rejection of B16 melanoma in the setting of regulatory T cell depletion and homeostatic proliferation

Impact of Pre-Treatment Whole-Body Metabolic Tumor Volume on Toxicities and Outcomes in Patients Treated with Anti-CD19 CAR T-Cell Therapy for Aggressive Large B-Cell NHL

Suchergebnisse filtern